The utility of antibodies as reagents is of paramount importance in research, diagnosis and clinical development.
This article outlines the steps for polyclonal antibody production, discussing key animal species for immunization, the selection of an appropriate adjuvant system, effective immunization routes for antigenadjuvant administration and post-immunization monitoring.
Polyclonal antibodies (pAbs) serve as essential reagents in biological research, drug development, diagnostics and clinical development.
Generating and characterizing pAbs for pharmaceutical uses requires careful planning to ensure quality results.
Download your copy today and:
This is the second in a series of three white papers reviewing the custom antibody production and the use antibodies in the development of therapeutic products. In this white paper 'Considerations in the production of antibodies as reagents: Polyclonal antibodies'
- Discover the 5 key steps of optimal pAb production
- Learn about the process and timelines related to the production of purified pAbs
- Understand the importance quality testing can provide assurance that any a given antibody will perform as projected
